Post-Effective Amendment No. 1 to FORM F-3

As filed with the Securities and Exchange Commission on January 21, 2020

Registration No. 333-230630

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

POST-EFFECTIVE AMENDMENT NO. 1

TO

FORM F-3

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

Zai Lab Limited

(Exact name of Registrant as specified in its charter)

 

 

 

Cayman Islands   98-1144595
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)

4560 Jinke Road

Bldg. 1, Fourth Floor

Pudong, Shanghai, China 201210

+86 21 6163 2588

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Cogency Global Inc.

10 E. 40th Street, 10th Floor

New York, NY 10016

Telephone: (800) 221 0102

(Name, address, including zip code, and telephone number, including area code, of agent for service))

 

 

Please send copies of all communications to:

 

Samantha Du   James C. Lin Esq.

Chief Executive Officer

Zai Lab Limited

4560 Jinke Road,

Bldg. 1, Fourth Floor

Pudong

Shanghai, China 201210

Telephone: +86 21 6163 2588

 

Davis Polk & Wardwell LLP

c/o 18th Floor,

The Hong Kong Club Building

3A Chater Road

Central, Hong Kong

Telephone: +852-2533-3300

 

 

Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.  ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.  ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.  ☒

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company  ☐

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

 

The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Each Class of
Securities to be Registered (1)
  Amount to be
Registered (2)
  Proposed Maximum
Offering Price Per
Unit (2)
  Proposed Maximum
Aggregate Offering
Price (2)
  Amount of
Registration Fee (2)

Ordinary Shares, par value US$0.00006 per share (3)(4)

  —     —     —     —  

 

 

 

(1)

Includes securities initially offered and sold outside the United States that may be resold from time to time in the United States either as part of their distribution or within 40 days after the later of the effective date of this registration statement and the date the securities are first bona fide offered to the public. These securities are not being registered for the purposes of sales outside of the United States.

(2)

An indeterminate aggregate initial offering price or number of the securities of each identified class is being registered as may from time to time be offered at indeterminate prices. In accordance with Rules 456(b) and 457(r), the Registrant is deferring payment of all of the registration fee. Registration fees will be paid subsequently on a pay as you go basis.

(3)

To be issued by Zai Lab Limited.

(4)

The Ordinary Shares may be represented by American depositary shares or ADSs, each of which represents one Ordinary Share. ADSs issuable upon deposit of ordinary shares registered hereby, have been registered under a separate registration statement on Form F-6 (Registration No. 333-220256).

 

 

 


EXPLANATORY NOTE

Zai Lab Limited (the “Company”) is filing this Post-Effective Amendment No. 1 to its Registration Statement on Form F-3 (File No. 333-230630) (the “Registration Statement”) for the sole purpose of reporting that the Company is no longer an emerging growth company as defined in Rule 405 of the Securities Act of 1933, as amended. This Post-Effective Amendment No. 1 does not modify any provision of the Prospectus that forms a part of the Registration Statement and accordingly such Prospectus has not been included herein. This Post-Effective Amendment No. 1 shall become effective immediately upon filing with the Securities and Exchange Commission.

 

1


INDEX TO EXHIBITS

 

Exhibit
Number

  

Exhibit Title

  1.1*    Form of Underwriting Agreement
  5.1**    Opinion of Travers Thorp Alberga regarding the validity of the ordinary shares being registered
23.1    Consent of Deloitte Touche Tohmatsu Certified Public Accountants LLP
23.2**    Consent of Travers Thorp Alberga (included in Exhibit 5.1)
24.1**    Power of Attorney of Kai-Xian Chen, John Diekman, Tao Fu, Nisa Leung, Peter Wirth and William Lis
24.2    Power of Attorney of Leon O. Moulder Jr.

 

*

To be filed by amendment or as an exhibit to a document to be incorporated by reference into this registration statement.

**

Previously filed.

 

II-1


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this Post-Effective Amendment No. 1 to Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Shanghai, the People’s Republic of China, on January 21, 2020.

 

ZAI LAB LIMITED
By:  

/s/ SAMANTHA DU

  Name:    Samantha Du
  Title:      Chief Executive Officer

 

II-2


Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Name

  

Title

 

Date

/s/ SAMANTHA DU

    
Samantha Du   

Chief Executive Officer, Chairman
of the Board of Directors

(Principal Executive Officer)

 

January 21, 2020

/s/ WILLIAM KI CHUL CHO

    
William Ki Chul Cho   

Chief Financial Officer

(Principal Financial and
Accounting Officer)

 

January 21, 2020

*

    
Kai-Xian Chen    Director  

January 21, 2020

*

    
John Diekman    Director  

January 21, 2020

*

    
Tao Fu    Director  

January 21, 2020

*

    
Nisa Leung    Director  

January 21, 2020

*

    
Peter Wirth    Director  

January 21, 2020

*

    
William Lis    Director  

January 21, 2020

/s/ LEON O. MOULDER JR.

    
Leon O. Moulder Jr.    Director   January 21, 2020

* By: /s/ Samantha Du

Name: Samantha Du

Title: Attornery-in-fact

 

II-3


SIGNATURE OF AUTHORIZED REPRESENTATIVE OF THE REGISTRANT

Under the Securities Act, the undersigned, the duly authorized representative in the United States of Zai Lab Limited, has signed this registration statement in New York, New York, on January 21, 2020.

 

Cogency Global Inc.

(Authorized U.S. Representative)

By:

 

/s/ Colleen A. De Vries

 

Name: Colleen A. De Vries

 

Title: Assistant Secretary

 

II-4

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in this Registration Statement No. 333-230630 on Form F-3 of our report dated March 29, 2019 relating to the consolidated financial statements and financial statement schedule of Zai Lab Limited and its subsidiaries (the “Group”), appearing in the Annual Report on Form 20-F of the Group for the year ended December 31, 2018, and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.

 

/s/ Deloitte Touche Tohmatsu Certified Public Accountants LLP
Shanghai, China
January 21, 2020
EX-24.2

Exhibit 24.2

POWER OF ATTORNEY

The undersigned director of Zai Lab Limited hereby appoints each of Samantha Du and William Ki Chul Cho, and each of them singly, as attorney-in-fact for the undersigned, with full power of substitution and resubstitution, for and in the name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) and supplements to this registration statement on Form F-3 and any and all related registration statements pursuant to Rule 462(b) under the Securities Act, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, hereby ratifying and confirming all that said attorney-in-fact and agent, or its substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

/s/ LEON O. MOULDER JR.

Leon O. Moulder Jr.

  

Director

  

January 21, 2020